CheckMyRecalls

Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with… recall

Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

Published
18 Jun 2025
Agency
Health Canada
Country
Canada

The hazard

Product quality

Classification: Type I

What to do

Return the affected products to your local pharmacy for a replacement, and for proper disposal. If you are unsure whether your product is affected, check with your pharmacy. Consult a health care professional if you have used the affected product and you have health concerns. Report any health product-related side effects or complaints to Health Canada. Contact the companies if you have questions about their recall:Accel Pharma Inc., by contacting Betty Cory at Accel Quality Assurance by calling 416-271-4775, or by email at bcory@regxia.com

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official Health Canada notice

Source: Health Canada, published 18 Jun 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.